STOCKHOLM, Oct. 15, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, previously announced it received its first medical policy from a private insurance company. For a medtech company, this is one of the milestones that matters most: it means insurers now recognize the company's non-invasive skin assessment technology as a covered, reimbursable procedure.SciBase wants to become the world leader in non-invasive, high-precision skin assessment for cancer detection and skin barrier evaluation. Our long-term ambition, as previously communicated: a significant share of a market worth roughly $1 billion, at a gross margin target of 75%.